For the pathogenesis of CBF-AML, the “double hit” model is widely recognized at present, in which the molecular genetic alterations of AML1-ETO, CBFβ- MYH11, CCND1, and CCND2 play important roles (29, 30). This evidence concerns the gene RUNX1 and acute myeloid leukemia.